ArticleMolecular therapy : the journal of the American Society of Gene Therapy2020

The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors.

Changwen Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.